These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 28895958

  • 21. [Systemic therapy of atopic dermatitis].
    Heratizadeh A, Breuer K, Kapp A, Werfel T.
    Hautarzt; 2003 Oct; 54(10):937-45. PubMed ID: 14513240
    [Abstract] [Full Text] [Related]

  • 22. Systemic Agents for Severe Atopic Dermatitis in Children.
    Notaro ER, Sidbury R.
    Paediatr Drugs; 2015 Dec; 17(6):449-57. PubMed ID: 26547214
    [Abstract] [Full Text] [Related]

  • 23. IL-4 and IL-13 Inhibition in Atopic Dermatitis.
    Matsunaga MC, Yamauchi PS.
    J Drugs Dermatol; 2016 Aug 01; 15(8):925-9. PubMed ID: 27537991
    [Abstract] [Full Text] [Related]

  • 24. Atopic dermatitis: an evidence-based treatment update.
    Silverberg JI.
    Am J Clin Dermatol; 2014 Jul 01; 15(3):149-64. PubMed ID: 24464934
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Immunosuppressive and immunomodulating therapy for atopic dermatitis in pregnancy: an appraisal of the literature.
    Drljevic-Nielsen A, Heilskov S, Deleuran MS, Vestergaard C.
    Ital J Dermatol Venerol; 2024 Feb 01; 159(1):23-33. PubMed ID: 38226937
    [Abstract] [Full Text] [Related]

  • 27. Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres.
    Garritsen FM, Roekevisch E, van der Schaft J, Deinum J, Spuls PI, de Bruin-Weller MS.
    J Eur Acad Dermatol Venereol; 2015 Oct 01; 29(10):1905-12. PubMed ID: 25752497
    [Abstract] [Full Text] [Related]

  • 28. Use of oral immunosuppressive drugs in the treatment of atopic dermatitis in the Netherlands.
    Garritsen FM, van den Heuvel JM, Bruijnzeel-Koomen CAFM, Maitland-van der Zee AH, van den Broek MPH, de Bruin-Weller MS.
    J Eur Acad Dermatol Venereol; 2018 Aug 01; 32(8):1336-1342. PubMed ID: 29485224
    [Abstract] [Full Text] [Related]

  • 29. Atopic dermatitis: systemic immunosuppressive therapy.
    Akhavan A, Rudikoff D.
    Semin Cutan Med Surg; 2008 Jun 01; 27(2):151-5. PubMed ID: 18620137
    [Abstract] [Full Text] [Related]

  • 30. Dupilumab for treatment of atopic dermatitis.
    Seegräber M, Srour J, Walter A, Knop M, Wollenberg A.
    Expert Rev Clin Pharmacol; 2018 May 01; 11(5):467-474. PubMed ID: 29557246
    [Abstract] [Full Text] [Related]

  • 31. Atopic dermatitis: emerging therapies.
    Simpson E, Udkoff J, Borok J, Tom W, Beck L, Eichenfield LF.
    Semin Cutan Med Surg; 2017 Sep 01; 36(3):124-130. PubMed ID: 28895959
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Guidelines for the Management of Atopic Dermatitis in Singapore.
    Tay YK, Chan YC, Chandran NS, Ho MS, Koh MJ, Lim YL, Tang MB, Thirumoorthy T.
    Ann Acad Med Singap; 2016 Oct 01; 45(10):439-450. PubMed ID: 27832218
    [Abstract] [Full Text] [Related]

  • 34. Systemic therapies for pediatric atopic dermatitis: a review for the primary care physician.
    Shaw MG, Burkhart CN, Morrell DS.
    Pediatr Ann; 2009 Jul 01; 38(7):380-7. PubMed ID: 19685658
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council.
    Simpson EL, Bruin-Weller M, Flohr C, Ardern-Jones MR, Barbarot S, Deleuran M, Bieber T, Vestergaard C, Brown SJ, Cork MJ, Drucker AM, Eichenfield LF, Foelster-Holst R, Guttman-Yassky E, Nosbaum A, Reynolds NJ, Silverberg JI, Schmitt J, Seyger MMB, Spuls PI, Stalder JF, Su JC, Takaoka R, Traidl-Hoffmann C, Thyssen JP, van der Schaft J, Wollenberg A, Irvine AD, Paller AS.
    J Am Acad Dermatol; 2017 Oct 01; 77(4):623-633. PubMed ID: 28803668
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Managing atopic dermatitis with systemic therapies in adults and adolescents: An Australian/New Zealand narrative.
    Rademaker M, Agnew K, Andrews M, Baker C, Foley P, Gebauer K, Gupta M, Rubel DM, Somerville C, Sullivan J, Wong LC.
    Australas J Dermatol; 2020 Feb 01; 61(1):9-22. PubMed ID: 31529493
    [Abstract] [Full Text] [Related]

  • 40. Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years: a Delphi consensus project mapping expert opinion in Northern Europe.
    de Graaf M, Janmohamed SR, Schuttelaar MLA, Agner T, Alfonso JH, De Schepper S, Deleuran M, Despontin K, Elenius V, Ghislain PD, Huilaja L, Johansson EK, Kvenshagen BK, Mandelin JM, Olset H, Svensson A, van Tuyll van Serooskerken AM, Thyssen JP, Vestergaard C.
    J Eur Acad Dermatol Venereol; 2022 Nov 01; 36(11):2153-2165. PubMed ID: 35793471
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.